title: A Novel Compound Heterozygous Mutation in the CYP4V2 Gene in a Japanese Patient with Bietti's Crystalline Corneoretinal Dystrophy.
abstract: OBJECTIVE
  To describe the clinical and genetic characteristics of a Japanese family in which one member exhibited Bietti's crystalline corneoretinal dystrophy (BCD).
  
  
  METHODS
  Using direct sequencing, mutation screening was performed in the CYP4V2 gene of both the patient with BCD and her daughter. Ophthalmic examinations were performed to determine the clinical features of both subjects.
  
  
  RESULTS
  The 64-year-old female patient had a bilateral visual acuity of 0.4. Slit lamp examination revealed bilateral crystalline-like deposits at the superior limbus of the cornea. Fundus examination revealed there was chorioretinal atrophy along with numerous glistening yellowish-white crystalline deposits that were scattered throughout the posterior pole and the mid-peripheral retina. Standard flash electroretinography showed an extinguished electroretinogram and Goldmann kinetic perimetry detected a relative scotoma. Genetic analysis revealed that the patient had a heterozygous mutation in the CYP4V2 gene (IVS6-8delTCATACAGGTCATCGCG/GC), which is the most commonly found mutation in Japanese patients with BCD. Furthermore, the patient was also shown to have a novel heterozygous point mutation in exon 9 of the CYP4V2 gene (c.1168C>T). In contrast, her daughter exhibited no clinical findings for BCD even though she carried the same heterozygous mutation in the CYP4V2 gene (c.1168C>T).
  
  
  CONCLUSIONS
  A novel compound heterozygous mutation was found in the CYP4V2 gene of a patient with BCD. This previously unreported c.1168C>T mutation causes a missense mutation (p.R390C) in the CYP4V2 protein.
authors.affiliation: Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Yokoi
authors.forename: Kota
authors.initials: K
authors.lastname: Sato
authors.forename: Hajime
authors.initials: H
authors.lastname: Aoyagi
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Minako
authors.initials: M
authors.lastname: Yamagami
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Nakazawa
references.citation: Am J Hum Genet. 2004 May;74(5):817-26
references.pmid: 15042513
references.citation: Am J Ophthalmol. 1994 Nov 15;118(5):569-82
references.pmid: 7977570
references.citation: Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1707-14
references.pmid: 11431432
references.citation: Arch Ophthalmol. 1989 Feb;107(2):213-21
references.pmid: 2783846
references.citation: Drug Metab Dispos. 2009 Nov;37(11):2119-22
references.pmid: 19661213
references.citation: Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3812-6
references.pmid: 16186368
references.citation: Am J Ophthalmol. 2005 May;139(5):894-9
references.pmid: 15860296
references.citation: Biochem Biophys Res Commun. 2011 Jun 3;409(2):181-6
references.pmid: 21565171
references.citation: J Med Genet. 2005 Jun;42(6):e38
references.pmid: 15937078
references.citation: Ophthalmic Res. 2005 Sep-Oct;37(5):262-9
references.pmid: 16088246
references.citation: Jpn J Ophthalmol. 2006 Sep-Oct;50(5):426-431
references.pmid: 17013694
references.citation: Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5212-20
references.pmid: 17962476